{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T12:09:55Z","timestamp":1779883795036,"version":"3.53.1"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T00:00:00Z","timestamp":1694736000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004505","name":"University of Catania","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004505","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","diabetesresearchclinicalpractice.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes Research and Clinical Practice"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.diabres.2023.110907","type":"journal-article","created":{"date-parts":[[2023,9,12]],"date-time":"2023-09-12T02:15:53Z","timestamp":1694484953000},"page":"110907","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Glycometabolic outcomes in adult type 1 diabetic patients switching to closed-loop systems"],"prefix":"10.1016","volume":"204","author":[{"given":"Giuseppe","family":"Papa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rossella","family":"Cannarella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosita A.","family":"Condorelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Concetta","family":"Finocchiaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aldo E.","family":"Calogero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandro","family":"La Vignera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.diabres.2023.110907_b0005","doi-asserted-by":"crossref","unstructured":"Diabetes Control and Complications Trial Research Group; Nathan DM, Genuth S, Lachin J, Cleary P, Crofford O, Davis M, et al. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993 Sep 30;329(14):977-86. doi: 10.1056\/NEJM199309303291401. PMID: 8366922.","DOI":"10.1056\/NEJM199309303291401"},{"key":"10.1016\/j.diabres.2023.110907_b0010","doi-asserted-by":"crossref","unstructured":"Diabetes Control and Complications Trial\/Epidemiology of Diabetes Interventions and Complications Research Group; Lachin JM, Genuth S, Cleary P, Davis MD, Nathan DM. Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy. N Engl J Med. 2000 Feb 10;342(6):381-9. doi: 10.1056\/NEJM200002103420603. Erratum in: N Engl J Med 2000 May 4;342(18):1376. PMID: 10666428; PMCID: PMC2630213.","DOI":"10.1056\/NEJM200005043421820"},{"issue":"6","key":"10.1016\/j.diabres.2023.110907_b0015","doi-asserted-by":"crossref","first-page":"421","DOI":"10.7326\/0003-4819-141-6-200409210-00007","article-title":"Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus","volume":"141","author":"Selvin","year":"2004","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.diabres.2023.110907_b0020","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ahj.2005.09.015","article-title":"Glycemic control and macrovascular disease in types 1 and 2 diabetes mellitus: Meta-analysis of randomized trials","volume":"152","author":"Stettler","year":"2006","journal-title":"Am Heart J"},{"key":"10.1016\/j.diabres.2023.110907_b0025","doi-asserted-by":"crossref","unstructured":"Foster NC, Beck RW, Miller KM, Clements MA, Rickels MR, DiMeglio LA, et al. State of Type 1 Diabetes Management and Outcomes from the T1D Exchange in 2016-2018. Diabetes Technol Ther. 2019 Feb;21(2):66-72. doi: 10.1089\/dia.2018.0384. Epub 2019 Jan 18. Erratum in: Diabetes Technol Ther. 2019 Apr;21(4):230. PMID: 30657336; PMCID: PMC7061293.","DOI":"10.1089\/dia.2018.0384"},{"key":"10.1016\/j.diabres.2023.110907_b0030","unstructured":"Diabete tipo 1. Annali Associazione Medici Diabetologi (AMD) 2020. https:\/\/aemmedi.it\/nuovi-annali-amd-2020\/."},{"issue":"6","key":"10.1016\/j.diabres.2023.110907_b0035","doi-asserted-by":"crossref","first-page":"750","DOI":"10.4158\/EP.14.6.750","article-title":"Hypoglycemia: still the limiting factor in the glycemic management of diabetes","volume":"14","author":"Cryer","year":"2008","journal-title":"Endocr Pract"},{"issue":"9","key":"10.1016\/j.diabres.2023.110907_b0040","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1111\/dme.12247","article-title":"Hypoglycaemia, fear of hypoglycaemia and quality of life in children with Type 1 diabetes and their parents","volume":"30","author":"Johnson","year":"2013","journal-title":"Diabet Med"},{"issue":"5","key":"10.1016\/j.diabres.2023.110907_b0045","doi-asserted-by":"crossref","first-page":"922","DOI":"10.2337\/dc07-2029","article-title":"Acute complications and drug misuse are important causes of death for children and young adults with type 1 diabetes: results from the Yorkshire Register of diabetes in children and young adults","volume":"31","author":"Feltbower","year":"2008","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1016\/j.diabres.2023.110907_b0050","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1007\/s00125-005-0082-6","article-title":"Long-term mortality in a nationwide cohort of childhood-onset type 1 diabetic patients in Norway","volume":"49","author":"Skrivarhaug","year":"2006","journal-title":"Diabetologia"},{"key":"10.1016\/j.diabres.2023.110907_b0055","doi-asserted-by":"crossref","unstructured":"Abraham MB, Nicholas JA, Smith GJ, Fairchild JM, King BR, Ambler GR, et al. PLGM Study Group. Reduction in Hypoglycemia With the Predictive Low-Glucose Management System: A Long-term Randomized Controlled Trial in Adolescents With Type 1 Diabetes. Diabetes Care. 2018 Feb;41(2):303-310. doi: 10.2337\/dc17-1604. Epub 2017 Nov 30. PMID: 29191844.","DOI":"10.2337\/dc17-1604"},{"issue":"10","key":"10.1016\/j.diabres.2023.110907_b0060","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.2337\/dc18-0771","article-title":"Predictive Low-Glucose Suspend Reduces Hypoglycemia in Adults, Adolescents, and Children With Type 1 Diabetes in an At-Home Randomized Crossover Study: Results of the PROLOG Trial","volume":"41","author":"Forlenza","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2023.110907_b0065","doi-asserted-by":"crossref","unstructured":"Faulds ER, Zappe J, Dungan KM. Real-world implications of hybrid close loop (HCL) insulin delivery system. Endocr Pract. 2019 May;25(5):477-484. doi: 10.4158\/EP-2018-0515. Epub 2019 Mar 13. PMID: 30865545; PMCID: PMC6832708.","DOI":"10.4158\/EP-2018-0515"},{"issue":"1","key":"10.1016\/j.diabres.2023.110907_b0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/dia.2022.0421","article-title":"Improved Glycemia with Hybrid Closed-Loop Versus Continuous Subcutaneous Insulin Infusion Therapy: Results from a Randomized Controlled Trial","volume":"25","author":"Garg","year":"2023","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/j.diabres.2023.110907_b0075","doi-asserted-by":"crossref","unstructured":"Breton MD, Kovatchev BP. One Year Real-World Use of the Control-IQ Advanced Hybrid Closed-Loop Technology. Diabetes Technol Ther. 2021 Sep;23(9):601-608. doi: 10.1089\/dia.2021.0097. Epub 2021 Apr 21. PMID: 33784196; PMCID: PMC8501470.","DOI":"10.1089\/dia.2021.0097"},{"key":"10.1016\/j.diabres.2023.110907_b0080","doi-asserted-by":"crossref","unstructured":"Pinsker JE, M\u00fcller L, Constantin A, Leas S, Manning M, McElwee Malloy M, et al. Real-World Patient-Reported Outcomes and Glycemic Results with Initiation of Control-IQ Technology. Diabetes Technol Ther. 2021 Feb;23(2):120-127. doi: 10.1089\/dia.2020.0388. Epub 2020 Sep 10. PMID: 32846114; PMCID: PMC7868573.","DOI":"10.1089\/dia.2020.0388"},{"issue":"2","key":"10.1016\/j.diabres.2023.110907_b0085","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1089\/dia.2021.0203","article-title":"Real-World Performance of the MiniMed\u2122 780G System: First Report of Outcomes from 4120 Users","volume":"24","author":"Silva","year":"2022","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/j.diabres.2023.110907_b0090","unstructured":"Arrieta A, Battelino T, Scaramuzza AE, Da Silva J, Casta\u00f1eda J, Cordero TL, et al. Comparison of MiniMed 780G system."},{"key":"10.1016\/j.diabres.2023.110907_b0095","doi-asserted-by":"crossref","unstructured":"ElSayed NA, Aleppo G, Aroda VR, Bannuru RR, Brown FM, Bruemmer D, et al., on behalf of the American Diabetes Association. 7. Diabetes Technology: Standards of Care in Diabetes-2023. Diabetes Care. 2023 Jan 1;46(Suppl 1):S111-S127. doi: 10.2337\/dc23-S007. PMID: 36507635; PMCID: PMC9810474.","DOI":"10.2337\/dc23-S007"},{"key":"10.1016\/j.diabres.2023.110907_b0100","article-title":"La terapia del diabete tipo 1. Sistema Nazionale delle Linee Guida Dell\u2019Istituto Superiore di Sanit\u00e0","author":"Linee Guida AMD-SID-SIEDP","year":"2022","journal-title":"Roma"},{"issue":"6","key":"10.1016\/j.diabres.2023.110907_b0105","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.eprac.2021.04.008","article-title":"American association of clinical endocrinology clinical practice guideline: the use of advanced technology in the management of persons with diabetes mellitus","volume":"27","author":"Grunberger","year":"2021","journal-title":"Endocr Pract"},{"issue":"3","key":"10.1016\/j.diabres.2023.110907_b0110","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1089\/dia.2019.0216","article-title":"Development and Validation of the Continuous Subcutaneous Insulin Infusion-Related Quality-of-Life (CSII-QOL) Scale","volume":"22","author":"Sakane","year":"2020","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/j.diabres.2023.110907_b0115","doi-asserted-by":"crossref","unstructured":"Carlson AL, Bode BW, Brazg RL, Christiansen MP, Garg SK, Kaiserman K, et al. 97-LB: Safety and Glycemic Outcomes of the MiniMed Advanced Hybrid Closed-Loop (AHCL) System in Subjects with T1D. Diabetes 1 June 2020; 69 (Supplement_1): 97\u2013LB. https:\/\/doi.org\/10.2337\/db20-97-LB.","DOI":"10.2337\/db20-97-LB"},{"issue":"10","key":"10.1016\/j.diabres.2023.110907_b0120","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1007\/s00592-022-01937-5","article-title":"Switching to the Minimed\u2122 780G system achieves clinical targets for CGM in adults with type 1 diabetes regardless of previous insulin strategy and baseline glucose control","volume":"59","author":"Lepore","year":"2022","journal-title":"Acta Diabetol"},{"key":"10.1016\/j.diabres.2023.110907_b0125","doi-asserted-by":"crossref","unstructured":"Tornese G, Buzzurro F, Carletti C, Faleschini E, Barbi E. Six-Month Effectiveness of Advanced vs. Standard Hybrid Closed-Loop System in Children and Adolescents With Type 1 Diabetes Mellitus. Front Endocrinol (Lausanne). 2021 Nov 9;12:766314. doi: 10.3389\/fendo.2021.766314. PMID: 34858339; PMCID: PMC8630740.","DOI":"10.3389\/fendo.2021.766314"},{"key":"10.1016\/j.diabres.2023.110907_b0130","doi-asserted-by":"crossref","unstructured":"Bergenstal RM, Nimri R, Beck RW, Criego A, Laffel L, Schatz D, et al. FLAIR Study Group. A comparison of two hybrid closed-loop systems in adolescents and young adults with type 1 diabetes (FLAIR): a multicentre, randomised, crossover trial. Lancet. 2021 Jan 16;397(10270):208-219. doi: 10.1016\/S0140-6736(20)32514-9. PMID: 33453783; PMCID: PMC9194961.","DOI":"10.1016\/S0140-6736(20)32514-9"},{"issue":"9","key":"10.1016\/j.diabres.2023.110907_b0135","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1089\/dia.2021.0037","article-title":"Rapid Improvement in Time in Range After the Implementation of an Advanced Hybrid Closed-Loop System in Adolescents and Adults with Type 1 Diabetes","volume":"23","author":"Beato-V\u00edbora","year":"2021","journal-title":"Diabetes Technol Ther"},{"issue":"8","key":"10.1016\/j.diabres.2023.110907_b0140","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.2337\/dc19-1785","article-title":"Time in Range for Multiple Technologies in Type 1 Diabetes: A Systematic Review and Network Meta-analysis","volume":"43","author":"Pease","year":"2020","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.diabres.2023.110907_b0145","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s12902-022-00996-7","article-title":"Glycemic outcomes of Advanced Hybrid Closed Loop system in children and adolescents with Type 1 Diabetes, previously treated with Multiple Daily Injections (MiniMed 780G system in T1D individuals, previously treated with MDI)","volume":"22","author":"Petrovski","year":"2022","journal-title":"BMC Endocr Disord"},{"key":"10.1016\/j.diabres.2023.110907_b0150","doi-asserted-by":"crossref","unstructured":"Petrovski G, Al Khalaf F, Campbell J, Umer F, Almajaly D, Hamdan M, et al. One-year experience of hybrid closed-loop system in children and adolescents with type 1 diabetes previously treated with multiple daily injections: drivers to successful outcomes. Acta Diabetol. 2021 Feb;58(2):207-213. doi: 10.1007\/s00592-020-01607-4. Epub 2020 Oct 12. PMID: 33044604; PMCID: PMC7548407.","DOI":"10.1007\/s00592-020-01607-4"},{"key":"10.1016\/j.diabres.2023.110907_b0155","doi-asserted-by":"crossref","unstructured":"Garg SK, Weinzimer SA, Tamborlane WV, Buckingham BA, Bode BW, Bailey TS, et al. Glucose Outcomes with the In-Home Use of a Hybrid Closed-Loop Insulin Delivery System in Adolescents and Adults with Type 1 Diabetes. Diabetes Technol Ther. 2017 Mar;19(3):155-163. doi: 10.1089\/dia.2016.0421. Epub 2017 Jan 30. PMID: 28134564; PMCID: PMC5359676.","DOI":"10.1089\/dia.2016.0421"},{"key":"10.1016\/j.diabres.2023.110907_b0160","doi-asserted-by":"crossref","unstructured":"Carlson AL, Sherr JL, Shulman DI, Garg SK, Pop-Busui R, Bode BW, et al. Safety and Glycemic Outcomes During the MiniMed\u2122 Advanced Hybrid Closed-Loop System Pivotal Trial in Adolescents and Adults with Type 1 Diabetes. Diabetes Technol Ther. 2022 Mar;24(3):178-189. doi: 10.1089\/dia.2021.0319. Epub 2021 Nov 16. PMID: 34694909; PMCID: PMC8971997.","DOI":"10.1089\/dia.2021.0319"},{"issue":"11","key":"10.1016\/j.diabres.2023.110907_b0165","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.2337\/dc22-0470","article-title":"Transitioning of People With Type 1 Diabetes From Multiple Daily Injections and Self-Monitoring of Blood Glucose Directly to MiniMed 780G Advanced Hybrid Closed-Loop System: A Two-Center, Randomized","volume":"45","author":"Matejko","year":"2022","journal-title":"Controlled Study Diabetes Care"},{"issue":"7","key":"10.1016\/j.diabres.2023.110907_b0170","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1016\/j.numecd.2022.03.031","article-title":"Minimed Medtronic 780G optimizes glucose control in patients with type 1 diabetes mellitus","volume":"32","author":"Pintaudi","year":"2022","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"10.1016\/j.diabres.2023.110907_b0175","doi-asserted-by":"crossref","unstructured":"Mameli C, Smylie GM, Galati A, Rapone B, Cardona-Hernandez R, Zuccotti G, et al. Safety, metabolic and psychological outcomes of Medtronic MiniMed 670G in children, adolescents and young adults: a systematic review. Eur J Pediatr. 2023 May;182(5):1949-1963. doi: 10.1007\/s00431-023-04833-4. Epub 2023 Feb 21. PMID: 36809498; PMCID: PMC9942055.","DOI":"10.1007\/s00431-023-04833-4"},{"key":"10.1016\/j.diabres.2023.110907_b0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2022.110225","article-title":"Effects of initiating insulin pump therapy in the real world: A nationwide, register-based study of adults with type 1 diabetes","volume":"196","author":"Madsen","year":"2023","journal-title":"Diabetes Res Clin Pract"},{"issue":"13","key":"10.1016\/j.diabres.2023.110907_b0185","doi-asserted-by":"crossref","first-page":"1036808","DOI":"10.3389\/fendo.2022.1036808","article-title":"Body mass index, basal insulin and glycemic control in children with type 1 diabetes treated with the advanced hybrid closed loop system remain stable - 1-year prospective, observational, two-center study","volume":"11","author":"Seget","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.diabres.2023.110907_b0190","doi-asserted-by":"crossref","unstructured":"Messer LH, Berget C, Vigers T, Pyle L, Geno C, Wadwa RP, et al. Real world hybrid closed-loop discontinuation: Predictors and perceptions of youth discontinuing the 670G system in the first 6 months. Pediatr Diabetes. 2020 Mar;21(2):319-327. doi: 10.1111\/pedi.12971. Epub 2020 Jan 3. PMID: 31885123; PMCID: PMC7204392.","DOI":"10.1111\/pedi.12971"}],"container-title":["Diabetes Research and Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822723006708?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822723006708?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T19:27:03Z","timestamp":1759174023000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168822723006708"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":38,"alternative-id":["S0168822723006708"],"URL":"https:\/\/doi.org\/10.1016\/j.diabres.2023.110907","relation":{},"ISSN":["0168-8227"],"issn-type":[{"value":"0168-8227","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Glycometabolic outcomes in adult type 1 diabetic patients switching to closed-loop systems","name":"articletitle","label":"Article Title"},{"value":"Diabetes Research and Clinical Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diabres.2023.110907","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"110907"}}